Track KPTI and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
KPTI - Karyopharm Therapeutics Inc (KPTI) has a earnings per share of -$1.24, up 55.2% over the past year.
Latest EPS (Actual)
-$1.24
Beat Rate
37.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$1.44 | -$1.24 | Beat | +13.89% |
| Feb 2026 | -$2.00 | -$2.23 | Miss | -11.50% |
| Nov 2025 | -$3.25 | -$3.82 | Miss | -17.54% |
| Aug 2025 | -$3.91 | -$4.07 | Meet | -4.09% |
| May 2025 | -$3.09 | -$2.77 | Beat | +10.36% |
| Feb 2025 | -$4.03 | -$3.60 | Beat | +10.67% |
| Nov 2024 | -$3.92 | -$3.90 | Meet | +0.51% |
| Aug 2024 | -$4.47 | -$4.34 | Meet | +2.91% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.